Biowound REG, the latest in Chronic wound healing

By: DCare and Meba Medical UK
READING, U.K. - April 1, 2015 - PRLog -- DCare and Meba UK, the leader in regenerative medicine, introduce the latest technology of the biologic wound healing device { Biowound REG }.

Wound healing is a dynamic interactive process that involves a sequence of molecular and cellular events. Recent advances in cellular and molecular biology have greatly expanded our understanding of the biological process involved in wound repair and tissue regeneration. From plasma extravasation, with coagulation and platelet aggregation to reepithelialization and remodeling of injured tissue, the organism acts by trying to restore tissue functionality, the immune system plays an integral role in successful wound healing. In addition to contributing to host defenses and inflammation, immune cells are critical regulators of wound healing through the secretion of cytokines, lymphokines, and growth factors. We review the mechanisms by which the immune system regulates wound healing, says Dr.Ihab Tadros The CEO and Founder of DCare and Meba Medical UK.

Biowound REG: The Latest Technology in Regenerative Medicine for wound healing, Biowound Reg is a dressing like device containing all the biological natural agents to restore the body biological processes for wound healing.

The Body Biological processes for repairing the damaged tissues are very complicated processes and controlled by several biological factors.

Immune suppression, specifically in Diabetic and older patients play an important roles in healing processes, also growth factors and stem cells inside the body are affected with several factors, which play a major roles in healing processes.

The absence of the majority of those factors is behind the wounds that change into Chronic wounds and may resist healing. Biowound REG is a medical device that contains specific particles rich with all biological factors required for wound healing. The product technology comes from several researches in regenerative medicine and NASA studies, says Dr. Beshoy Shehata, pharmacist, the technical manager of DCare and Meba Medical UK.

The product will be available in the market soon and will provide a new hope for patients suffering from chronic wounds with no hope of healing and those who may be facing limb amputation, says Dr.Ihab Tadros.

Media Contact
DCare and Meba Medical UK

Email:*** Email Verified
Tags:Wound, Biowound REG, Diabetes, Dcare, Meba
Industry:Manufacturing, Medical
Location:Reading - Berkshire - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Apr 01, 2015

Like PRLog?
Click to Share